Drug legislation. Drug companies divided.

Companies targeting drug delivery.

Legislation and drug safety.

The addiction of drug companies.

Generic drug companies are the winners.

Drug safety legislation closer to passing.

Insurance companies' perspectives on the orphan drug pipeline.

Drug Companies Breathe Easier As PDUFA VI Heads for Approval.

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history.

Drug companies' patient-assistance programs--helping patients or profits?

A Collaborative Assessment Among 11 Pharmaceutical Companies of Misinformation in Commonly Used Online Drug Information Compendia.

Disclosing payments from drug companies should be mandatory for doctors, says academy.

Market watch: Are orphan drug companies the pick of the pharmaceutical industry?

Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study.

Interactions between medical residents and drug companies: a national survey after the Mediator® affair.

Patients can't trust doctors' advice if we hide our financial connections with drug companies.

Brand name drug companies appear to hold winning hand in GATT talks.

Indirect payments from drug companies to doctors for CME courses will be exempt from database.

Drug parity legislation: states, organizations seek to make oral cancer drugs more affordable.

The impact of legislation on drug substances used off-label in paediatric wards--a nationwide study.

Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.

Increased Incidence of Spinal Abscess and Substance Abuse after Implementation of State Mandated Prescription Drug Legislation.

Drug repurposing based on drug-drug interaction.

Drug utilization and potential drug-drug interactions.

Cocaine drug-drug interactions.

Suggest Documents

Companies targeting drug delivery.

Legislation and drug safety.

The addiction of drug companies.

Generic drug companies are the winners.

Drug safety legislation closer to passing.

Insurance companies' perspectives on the orphan drug pipeline.

Drug Companies Breathe Easier As PDUFA VI Heads for Approval.

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history.

Drug companies' patient-assistance programs--helping patients or profits?

A Collaborative Assessment Among 11 Pharmaceutical Companies of Misinformation in Commonly Used Online Drug Information Compendia.

Disclosing payments from drug companies should be mandatory for doctors, says academy.

Market watch: Are orphan drug companies the pick of the pharmaceutical industry?

Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study.

Interactions between medical residents and drug companies: a national survey after the Mediator® affair.

Patients can't trust doctors' advice if we hide our financial connections with drug companies.

Brand name drug companies appear to hold winning hand in GATT talks.

Indirect payments from drug companies to doctors for CME courses will be exempt from database.

Drug parity legislation: states, organizations seek to make oral cancer drugs more affordable.

The impact of legislation on drug substances used off-label in paediatric wards--a nationwide study.

Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.

Increased Incidence of Spinal Abscess and Substance Abuse after Implementation of State Mandated Prescription Drug Legislation.

Drug repurposing based on drug-drug interaction.

Drug utilization and potential drug-drug interactions.

Cocaine drug-drug interactions.

Drug legislation. Drug companies divided.

Recommend Documents

Follow Us